These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19348179)

  • 81. The clinical and diagnostic role of anti-GM1 antibody testing.
    Kornberg AJ; Pestronk A
    Muscle Nerve; 1994 Jan; 17(1):100-4. PubMed ID: 8264687
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Sensory neuropathy associated with monoclonal immunoglobulin M to GD1b ganglioside.
    Daune GC; Farrer RG; Dalakas MC; Quarles RH
    Ann Neurol; 1992 Jun; 31(6):683-5. PubMed ID: 1381168
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Immunoadsorption in multifocal motor neuropathy.
    Finsterer J; Derfler K
    J Immunother; 1999 Sep; 22(5):441-2. PubMed ID: 10546160
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Chronic motor axonal neuropathy associated with antibodies monospecific for N-acetylgalactosaminyl GD1a.
    Kaji R; Kusunoki S; Mizutani K; Oka N; Kojima Y; Kohara N; Kimura J
    Muscle Nerve; 2000 May; 23(5):702-6. PubMed ID: 10797392
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Human IgM monoclonal proteins that bind 3-fucosyllactosamine, asialo-GM1, and GM1.
    Marcus DM; Perry L; Gilbert S; Preud'homme JL; Kyle R
    J Immunol; 1989 Nov; 143(9):2929-32. PubMed ID: 2572647
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Monoclonal IgM with unique specificity to gangliosides GM1 and GD1b and to lacto-N-tetraose associated with human motor neuron disease.
    Latov N; Hays AP; Donofrio PD; Liao J; Ito H; McGinnis S; Konstadoulakis M; Freddo L; Shy ME
    Neurology; 1988 May; 38(5):763-8. PubMed ID: 2452383
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
    Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N
    J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Multifocal motor neuropathy: diagnosis and treatment.
    Pestronk A
    Neurology; 1998 Dec; 51(6 Suppl 5):S22-4. PubMed ID: 9851726
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Detection of serum anti-ganglioside antibodies by latex agglutination assay in Guillain-Barré syndrome: comparison with ELISA.
    Irie S; Saito T; Kanazawa N; Ogino M; Ogino Y; Sakai F
    Intern Med; 2003 Jun; 42(6):490-5. PubMed ID: 12857046
    [TBL] [Abstract][Full Text] [Related]  

  • 90. T cell-independent B cell response to self-monosialogangliosides: primary response monoclonal antibodies.
    Alfonso M; Vázquez AM; Carr A; Haerslev T; Fernández LE; Lanio ME; Alvarez C; Zeuthen J; Pérez R
    Hybridoma; 1995 Jun; 14(3):209-16. PubMed ID: 7590782
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Ganglioside GD1b is the target antigen for a biclonal IgM in a case of sensory-motor axonal polyneuropathy: involvement of N-acetylneuraminic acid in the epitope.
    Younes-Chennoufi AB; Léger JM; Hauw JJ; Preud'homme JL; Bouche P; Aucouturier P; Ratinahirana H; Lubetzki C; Lyon-Caen O; Baumann N
    Ann Neurol; 1992 Jul; 32(1):18-23. PubMed ID: 1379422
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Multifocal motor neuropathy.
    Guimarães-Costa R; Bombelli F; Léger JM
    Presse Med; 2013 Jun; 42(6 Pt 2):e217-24. PubMed ID: 23623583
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Immunostaining of motor nerve terminals by IgM M protein with activity against gangliosides GM1 and GD1b from a patient with motor neuron disease.
    Schluep M; Steck AJ
    Neurology; 1988 Dec; 38(12):1890-2. PubMed ID: 2461538
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Do GM1 antibodies induce demyelination?
    Lange DJ; Trojaborg W
    Muscle Nerve; 1994 Jan; 17(1):105-7. PubMed ID: 8264688
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Multifocal motor neuropathy: current concepts and controversies.
    Nobile-Orazio E; Cappellari A; Priori A
    Muscle Nerve; 2005 Jun; 31(6):663-80. PubMed ID: 15770650
    [TBL] [Abstract][Full Text] [Related]  

  • 96. An antibody to the GM1/GalNAc-GD1a complex correlates with development of pure motor Guillain-Barré syndrome with reversible conduction failure.
    Ogawa G; Kaida K; Kuwahara M; Kimura F; Kamakura K; Kusunoki S
    J Neuroimmunol; 2013 Jan; 254(1-2):141-5. PubMed ID: 23000056
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The physiological effect of anti-GM1 antibodies on saltatory conduction and transmembrane currents in single motor axons.
    Hirota N; Kaji R; Bostock H; Shindo K; Kawasaki T; Mizutani K; Oka N; Kohara N; Saida T; Kimura J
    Brain; 1997 Dec; 120 ( Pt 12)():2159-69. PubMed ID: 9448571
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Sulfated glucuronyl glycolipids reacting with anti-myelin-associated glycoprotein monoclonal antibodies including IgM paraproteins in neuropathy: species distribution and partial characterization of epitopes.
    Ilyas AA; Dalakas MC; Brady RO; Quarles RH
    Brain Res; 1986 Oct; 385(1):1-9. PubMed ID: 2429733
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Diagnostic value of GM1 antibodies in motor neuron disorders and neuropathies: a meta-analysis.
    van Schaik IN; Bossuyt PM; Brand A; Vermeulen M
    Neurology; 1995 Aug; 45(8):1570-7. PubMed ID: 7644057
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Conduction abnormalities induced by sera of patients with multifocal motor neuropathy and anti-GM1 antibodies.
    Uncini A; Santoro M; Corbo M; Lugaresi A; Latov N
    Muscle Nerve; 1993 Jun; 16(6):610-5. PubMed ID: 8502258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.